arrow
返回
A

Ana Oaknin

Yonsei University Health System

71H指数
715论文数
3.6W被引数
收录论文 144
发表时间
Challenges in the use of the European Society for Radiotherapy and Oncology–European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer使用欧洲放射肿瘤学会–欧洲癌症研究和治疗组织寡转移性疾病分类系统在卵巢癌中的挑战
err2026-08-24
err0
PREAI
errGabriella Macchia; Alessio G Morganti; Alexandra Taylor; Nicole Concin; Ana Oaknin; Domenica Lorusso; Giuseppe Vizzielli; Remi Nout; Antonio González-Martín; Donato Pezzulla; Francesco Deodato; Fernanda G Herrera; Barbara Alicja Jereczek-Fossa; Matthias Guckenberger
err分享
err收藏
Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research第一届妇科肿瘤学组宫颈癌共识会议的临床研究共识声明
err2026-07-27
err0
PREAI
errBabita Kataria; Asima Mukhopadhyay; Ana Oaknin; Dearbhaile M O'Donnell; David S P Tan; David Cibula; Maaike C G Bleeker; Marie Plante; Cyrus Chargari; Alison Brand; Domenica Lorusso; Jyoti Mayadev; Alexandra Leary; Kosei Hasegawa; Elise C Kohn; Lucas C Mendez; Patrick J Maguire; Carmen Garcia-Duran; Kim Hanly; Parul Malhotra
err分享
err收藏
Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses曲妥珠单抗德鲁替康在DESTINY-PanTumor02研究中对HER2表达妇科癌症的抗肿瘤活性、安全性和探索性生物标志物分析
err2026-05-01
err0
PREAI
errLee, Jung-Yun; Oaknin, Ana; Manso, Luis; Gonzalez-Martin, Antonio; Lugowska, Iwona; Lorusso, Domenica; Banerjee, Susana; Liao, John B.; Lu, Chien-Hsing; Prasongsook, Naiyarat; Melichar, Bohuslav; Anoka, Chiedozie; Jung, Lindsey; Michelini, Flavia; Puvvada, Soham; Meric-Bernstam, Funda; Makker, Vicky
err分享
err收藏
Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancerIb期临床试验:评估SL-172154(一种双特异性CD47抑制剂和CD40激动剂Fc融合蛋白)联合mirvetuximab soravtansine或脂质体多柔比星治疗铂耐药性卵巢癌患者的疗效。
err2026-04-08
err0
PREAI
errYvette Drew; Lucy Gilbert; Alejandro Martinez Bueno; Ana Oaknin; Victor Moreno; Lydia Gaba Garcia; Gordon C. Jayson; Rebecca S. Kristeleit; Nehal Lakhani; Susana Banerjee; Daniela Matei; Amit Oza; Rowan Miller; Dennis Yiannakis; Maria-Pilar Barretina-Ginesta; Jerónimo Martínez García; Guanfang Wang; Jayalakshmi Miriyala; Amy Franke; Elisa Galvez; Lini Pandite; Debra L. Richardson
err分享
err收藏
The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201阿伐木单抗与德法他尼联用治疗复发性低级别浆液性卵巢癌:ENGOT-OV60/GOG-3052/RAMP 201 II期临床试验的通俗语言总结
err2025-12-12
err0
errOAAI
errSusana N. Banerjee; Els Van Nieuwenhuysen; Carol Aghajanian; Véronique D’Hondt; Bradley J. Monk; Andrew Clamp; Emily Prendergast; Ana Oaknin; Kari Ring; Nicoletta Colombo; Robert W. Holloway; Manuel Rodrigues; Hye Sook Chon; Charlie Gourley; Alessandro D. Santin; Premal H. Thaker; Christine Gennigens; Gregg Newman; Erin Salinas; Hagop Youssoufian; Kathleen N. Moore; Stephanie Lustgarten; David M. O’Malley; Toon Van Gorp; Rachel N. Grisham
err分享
err收藏
Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc
err2025-11-01
err0
errOAAI
errTakekuma, Munetaka; Nishio, Shin; Yamaguchi, Satoshi; Yunokawa, Mayu; Nishio, Hiroshi; Nishino, Koji; Kurosaki, Akira; Minobe, Shinichiro; Villacampa, Guillermo; Oaknin, Ana; Okamoto, Aikou
err分享
err收藏
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025ESGO–ESTRO–ESP关于子宫内膜癌患者管理的指南:2025年更新
err2025-07-28
err0
PREAI
errNicole Concin; Xavier Matias-Guiu; David Cibula; Nicoletta Colombo; Carien L Creutzberg; Jonathan Ledermann; Mansoor Raza Mirza; Ignace Vergote; Nadeem R Abu-Rustum; Tjalling Bosse; Cyrus Chargari; Sophie Espenel; Anna Fagotti; Christina Fotopoulou; Sonia Gatius; Antonio González-Martin; Sigurd Lax; Bar Levy; Domenica Lorusso; Gabriella Macchia; Christian Marth; Philippe Morice; Ana Oaknin; Maria Rosaria Raspollini; Richard Schwameis; Jalid Sehouli; Alina Sturdza; Alexandra Taylor; Anneke Westermann; Pauline Wimberger; François Planchamp; Remi A Nout
err分享
err收藏
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trialRucaparib用于铂敏感、复发性卵巢癌的维持治疗:III期、随机、安慰剂对照ARIEL3试验的最终结果
err2025-06-17
err0
errOAAI
errJonathan A. Ledermann; Amit M. Oza; Domenica Lorusso; Carol Aghajanian; Ana Oaknin; Andrew Dean; Nicoletta Colombo; Johanne I. Weberpals; Andrew R. Clamp; Giovanni Scambia; Alexandra Leary; Robert W. Holloway; Margarita Amenedo Gancedo; Peter C. Fong; Jeffrey C. Goh; David M. O’Malley; Deborah K. Armstrong; Susana Banerjee; Jesús García-Donas; Elizabeth M. Swisher; Robert L. Coleman
err分享
err收藏
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial在无胚系BRCA1和/或BRCA2突变且对铂类敏感的复发性卵巢癌患者中应用奥拉帕尼单药维持治疗:OPINION试验的最终总生存结果
err2025-06-01
err0
errOAAI
errPoveda, Andres; Lheureux, Stephanie; Colombo, Nicoletta; Cibula, David; Elstrand, Mari; Weberpals, Johanne; Bjurberg, Maria; Oaknin, Ana; Sikorska, Magdalena; Gonzalez-Martin, Antonio; Madry, Radoslaw; Perez, Maria Jesus Rubio; Ledermann, Jonathan; Romero, Ignacio; Ozgoren, Ozan; Barnicle, Alan; Marshall, Helen; Bashir, Zahid; Kof, Erik
err分享
err收藏
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancerGOG-3097/ENGOT-ov81/GTG-UK/RAMP 301:一项评估阿伏莫替尼联合达法他尼与研究者选择治疗方案相比,在复发性低级别浆液性卵巢癌患者中的随机III期试验
err2025-04-19
err0
errOAAI
errRachel Grisham; Bradley J. Monk; Els Van Nieuwenhuysen; Kathleen Nadine Moore; Michel Fabbro; David M. O’Malley; Ana Oaknin; Premal Thaker; Amit M. Oza; Nicoletta Colombo; David Gershenson; Carol A. Aghajanian; Chel Hun Choi; Yeh Chen Lee; Mansoor Raza Mirza; Robert L. Coleman; Lauren Cobb; Philipp Harter; Stephanie Lustgarten; Hagop Youssoufian; Susana Banerjee
err分享
err收藏
Molecular and clinical insights into early-onset endometrial cancer早期子宫内膜癌的分子与临床研究进展
err2025-03-25
err0
PREAI
errZimeng Wu; Zhe Hu; Qinlan Li; Geyan Liu; Ana Oaknin; Juan Francisco Grau Bejar; Gordon B. Mills; Ding Ma; Chaoyang Sun; Gang Chen
err分享
err收藏
Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02研究总结: 通过招募HER2 IHC状态: DESTINY-PanTumor02的事后分析,曲妥珠单抗Deruxtecan在HER2-Expressing实体瘤中的疗效
err2025-03-01
err0
errOAAI
errOaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda
err分享
err收藏
err分享
err收藏
Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial帕姆单抗(Cemiplimab)在复发性宫颈癌中的疗效:EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 III期临床试验的最终总生存期分析
err2025-02-01
err0
PREAI
errOaknin, Ana; Monk, Bradley J.; de Melo, Andreia Cristina; Kim, Hee Seung; Kim, Yong Man; Lisyanskaya, Alla S.; Samouelian, Vanessa; Lorusso, Domenica; Damian, Fernanda; Chang, Chih-Long; Gotovkin, Evgeniy; Takahashi, Shunji; Ramone, Daniella; Mackowiak-Matejczyk, Beata; Polastro, Laura; Alia, Eva Maria Guerra; Colombo, Nicoletta; Makarova, Yulia; Goh, Jeffrey C.; Hasegawa, Kosei; Mora, Paulo; Pikiel, Joanna; Srivastav, Ratnesh; Rischin, Danny; Rubio, Maria Jesus; Perez, Javier; Yoo, Suk Young; Gao, Bo; Jamil, Shaheda; Seebach, Frank; Lowy, Israel; Mathias, Melissa; Fury, Matthew G.; Tewari, Krishnansu S.
err分享
err收藏
Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY
err2024-11-08
err0
errOAAI
errKuchimanchi, Mita; Jorgensen, Trine Lembrecht; Hanze, Eva; Andre, Thierry; Jain, Angela; Berton, Dominique; Alskaer, Oskar; Zub, Oleksandr; Oaknin, Ana; Shahin, Mark S.; Koliadi, Anthoula; Pothuri, Bhavana; Krivak, Tom; Pishchyk, Mikalai; Segev, Yakir; Backes, Floor J.; Gennigens, Christine; Bouberhan, Sara; Zajic, Stefan; Melhem, Murad; Buscema, Joseph
err分享
err收藏
Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinomasimlukafusp alfa (FAP-IL2v) 联合阿特珠单抗治疗复发和/或转移性宫颈鳞状细胞癌患者的抗肿瘤活性和安全性的2期研究
err2024-11-01
err1
PREAI
errVerlingue, Loic; Italiano, Antoine; Prenen, Hans; Alia, Eva Maria Guerra; Tosi, Diego; Perets, Ruth; Lugowska, Iwona; Moiseyenko, Vladimir; Gumus, Mahmut; Arslan, Cagatay; Lindsay, Colin R.; Deva, Sanjeev; Taus, Alvaro; Oaknin, Ana; Rottey, Sylvie; Cicin, Irfan; Goksu, Sema Sezgin; Smolin, Alexey; Rosello-Keranen, Susana; Habigt, Christin; Marbach, Daniel; Boetsch, Christophe; Dejardin, David; Sleiman, Nassim; Evers, Stefan; Richard, Muriel; Ardeshir, Caroline; Charo, Jehad; Kraxner, Anton; Teichgraber, Volker; Keshelava, Nino; Dziadziuszkoz, Rafal
err分享
err收藏
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trialPembrolizumab或安慰剂联合放化疗,然后用pembrolizumab或安慰剂治疗新诊断的高危局部晚期宫颈癌 (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): 一项随机,双盲,安慰剂对照的3期试验的总生存期结果
errLANCET
IF88.5
err2024-10-01
err6
PREAI
errLorusso, Domenica; Xiang, Yang; Hasegawa, Kosei; Scambia, Giovanni; Leiva, Manuel; Ramos-Elias, Pier; Acevedo, Alejandro; Cvek, Jakub; Randall, Leslie; Gomes, Andrea Juliana Pereira de Santana; Mejia, Fernando Contreras; Helpman, Limor; Akilli, Huseyin; Lee, Jung-Yun; Saevets, Valeriya; Zagouri, Flora; Gilbert, Lucy; Sehouli, Jalid; Tharavichitkul, Ekkasit; Lindemann, Kristina; Colombo, Nicoletta; Chang, Chih-Long; Bednarikova, Marketa; Zhu, Hong; Oaknin, Ana; Christiaens, Melissa; Petru, Edgar; Usami, Tomoka; Liu, Peng; Yamada, Karin; Toker, Sarper; Keefe, Stephen M.; Pignata, Sandro; Duska, Linda R.
err分享
err收藏
Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02通过纳入HER2 IHC状态: DESTINY-PanTumor02的事后分析,曲妥珠单抗Deruxtecan在HER2-Expressing实体瘤中的疗效
err2024-09-11
err1
errOAAI
errOaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda
err分享
err收藏
Pembrolizumab or Placebo With Chemoradiotherapy Followed by Pembrolizumab or Placebo for Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): A Randomized, Double-Blind, Phase 3 Clinical TrialPembrolizumab或安慰剂联合放化疗,然后用Pembrolizumab或安慰剂治疗新诊断的高危局部晚期宫颈癌 (ENGOT-cx11/GOG-3047/KEYNOTE-A18): 一项随机,双盲,3期临床试验
err2024-09-01
err0
PREAI
errLorusso, Domenica; Xiang, Yang; Hasegawa, Kosei; Scambia, Giovanni; Leiva, Manuel; Ramos-Elias, Pier; Acevedo, Alejandro; Sukhin, Vladyslav; Cloven, Noelle; Gomes, Andrea J. Pereira de Santana; Mejia, Fernando Contreras; Reiss, Ari; Ayhan, Ali; Lee, Jung-Yun; Saevets, Valeriya; Zagouri, Flora; Gilbert, Lucy; Sehouli, Jalid; Tharavichitkul, Ekkasit; Lindemann, Kristina; Lazzari, Roberta; Chang, Chih-Long; Lampe, Rudolf; Zhu, Hong; Oaknin, Ana; Christiaens, Melissa; Polterauer, Stephan; Usami, Tomoka; Li, Kan; Yamada, Karin; Toker, Sarper; Keefe, Stephen M.; Pignata, Sandro; Duska, Linda R.
err分享
err收藏